Efficacy and Safety of Macular Edema Treatments from Network Meta-Analysis

2060 patients from 11 randomized controlled trials compare anti-VEGF agents and corticosteroids for macular edema secondary to central retinal vein occlusion. The data supports network meta-analysis of therapeutic effects on best-corrected visual acuity and central retinal thickness, and safety outcomes including intraocular pressure and cataracts. Results rank treatments like aflibercept and ranibizumab based on simulation.

Use Cases

• Rank treatment efficacy by simulating outcomes for proportions of patients gaining or losing ≥15 letters.
• Compare safety profiles of drugs like dexamethasone and ranibizumab using adverse event data for intraocular pressure and cataracts.
• Analyze the relationship between best-corrected visual acuity (BCVA) improvement and central retinal thickness (CRT) reduction across anti-VEGF agents.
• Conduct a benefit-risk analysis for treatments like aflibercept versus ranibizumab using combined efficacy and safety metrics from the network meta-analysis.

Strengths

• Data synthesizes evidence from 11 randomized controlled trials, a systematic foundation for analysis.
• Includes outcomes for 2060 patients, providing a substantial sample for comparative treatment assessment.
• Reports multiple clinical endpoints including BCVA, CRT, and specific adverse events like increased IOP and VH.

Limitations

• Literature search concluded in March 2017, so evidence may not include recent clinical trials or drug approvals.
• As a meta-analysis of existing RCTs, the dataset does not contain original patient-level records for granular analysis.
• The network meta-analysis methodology may inherit biases or heterogeneity from the included primary studies.

Provenance

Source

Systematic review and network meta-analysis of randomized controlled trials from PubMed, Medline, Embase, Cochrane Library, and clinicaltrials.gov.

Collection Method

Literature search and synthesis using software ADDIS (version 1.16.8) for network meta-analysis and treatment ranking.

Time Range

Literature search covered studies until March 2017.

Freshness

Last updated 2020-06-24, but underlying evidence is current only until March 2017.